...
首页> 外文期刊>Cardiology and therapy. >Proposal for New Classification and Practical Use of Diuretics According to Their Effects on the Serum Chloride Concentration: Rationale Based on the “Chloride Theory”
【24h】

Proposal for New Classification and Practical Use of Diuretics According to Their Effects on the Serum Chloride Concentration: Rationale Based on the “Chloride Theory”

机译:根据其对血氯浓度的影响,利尿剂的新分类和实际使用提案:基于“氯化物理论”的理由

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Currently, diuretic therapy for heart failure (HF) pathophysiology is primarily focused on the sodium and water balance. Over the last several years, however, chloride (Cl) has been recognized to have an important role in HF pathophysiology, as both a prognostic marker and a possible central factor regulating the body fluid status. I recently proposed a unifying hypothesis for HF pathophysiology, called the “chloride theory”, during HF worsening and recovery, as follows. Chloride is the key electrolyte for regulating both reabsorption of tubular electrolytes and water in the kidney through the renin–angiotensin–aldosterone system and distributing body fluid in each compartment of the body. As changes between the serum Cl concentration and plasma volume are intimately associated with worsening HF and its recovery after decongestive therapy, modulation of the serum Cl concentration by careful selection and combination of various diuretics and their doses could become an attractive therapeutic option for HF. In this review, I will propose a new classification and practical use of diuretics according to their effects on the serum Cl concentration. Diuretic use according to this classification is expected to be a useful strategy for the treatment of patients with HF.
机译:目前,对心力衰竭(HF)病理生理学的利尿疗法主要集中在钠和水平衡上。然而,在过去几年中,已经认识到氯化物(CL)在HF病理生理学中具有重要作用,作为预后标记和调节体液状态的可能的中枢因子。我最近提出了HF病理生理学的统一假设,称为“氯化物理论”,在HF恶化和恢复期间,如下所述。氯化物是通过肾素 - 血管紧张素 - 醛固酮系统在肾脏中的管状电解质和水的重吸收的关键电解质,并在身体的每个室中分配体液。随着血清Cl浓度和血浆体积之间的变化与恶化的HF浓度相关并在积极治疗后的恢复相关时,通过仔细选择和各种利尿剂的组合来调节血清Cl浓度,并且它们的剂量可以成为HF的有吸引力的治疗选择。在本综述中,我将根据其对血清Cl浓度的影响提出新的分类和实际使用利尿剂。预计根据该分类的利尿用途是治疗HF患者的有用策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号